Omnix Medical

📍 Jerusalem, Israel🗓 Founded 2015👥 25 employees💰 Last funded Apr 2021
Pharmaceutical Manufacturing🌐 omnixmedical.com
Website LinkedIn
Omnix Medical is a clinical company, dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains, a highly common problem in todays medicine especially in chronic conditions and in modern hospitals. These agents are based on natural antimicrobial peptides, genetically engineered to be compatible for therapeutic use. Omnix is addressing an enormous and rapidly growing market opportunity, represented by millions of Americans and many more millions worldwide, who suffer from infections associated with resistant bacteria.
4
Total investors
2
Early stage
0
Mid stage
2
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Investor activity2015–2021 · investors recorded per year
2015220212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Omnix Medical?
Omnix Medical has 4 investors on record on gritt.io, including 2 early-stage backers and 2 late-stage investors.
When did Omnix Medical last raise funding?
The most recent investment in Omnix Medical recorded on gritt.io was in April 2021.
When was Omnix Medical founded?
Omnix Medical was founded in 2015.
What industry is Omnix Medical in?
Omnix Medical operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Omnix Medical based?
Omnix Medical is headquartered in Jerusalem, Israel.